Vertex Pharmaceuticals Inc. stock rises Thursday, outperforms market
Shares of Vertex Pharmaceuticals Inc. VRTX, +1.09% rose 1.09% to $354.81 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX, +0.38% rising 0.38% to 4,567.80 and the Dow Jones Industrial Average DJIA, +1.47% rising 1.47% to 35,950.89.
This was the stock's second consecutive day of gains.
Vertex Pharmaceuticals Inc. closed $32.61 short of its 52-week high ($387.42), which the company achieved on November 6th.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as AbbVie Inc. ABBV, +2.81% rose 2.81% to $142.39, Krystal Biotech Inc. KRYS, +3.79% rose 3.79% to $104.23, and Arcturus Therapeutics Holdings Inc. ARCT, -1.24% fell 1.24% to $23.94.
Editor's Note: This story was auto-generated by Automated Insights , an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.
!["General Dynamics Corp. stock rises Friday, outperforms market"](https://img.theflashnews.co/"us/resources/article_images/30cfaccd-f27a-485f-b602-ce2728d149c6.jpg"?h=157&w=320&mode=stretch)
!["Paychex Inc. stock outperforms competitors on strong trading day"](https://img.theflashnews.co/"us/resources/article_images/2f38a505-f947-4290-857b-1a0d2dfe1dc0.jpg"?h=157&w=320&mode=stretch)
